Position in IQV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$19,322
+$2,268 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#942
of 1,077 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Costello Asset Management, INC holds $489,906 across 10 Diagnostics & Research names. IQV ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
652 | $326,886 | |
| 2 | A |
Agilent Technologies, Inc.
|
301 | $39,981 | |
| 3 | DHR |
Danaher Corp /De/
|
200 | $38,096 | |
| 4 | NTRA |
Natera, Inc.
|
100 | $27,145 | |
| 5 | DGX |
Quest Diagnostics Inc
|
100 | $21,195 | |
| 6 | IQV |
Iqvia Holdings Inc.
This page
|
100 | $19,322 | |
| 7 | RVTY |
Revvity, Inc.
|
100 | $11,126 | |
| 8 | QGEN |
Qiagen N.V.
|
100 | $3,910 |
All Filings in IQV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,322 | 100 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $17,054 | 100 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $22,541 | 100 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $18,994 | 100 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $15,759 | 100 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $17,630 | 100 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||